The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.

Patients with COPD who experience at least 1 moderate exacerbation may be at increased risk of all-cause mortality.

COPD is one of the top 10 leading cause of death in the U.S., the CDC says.

Chronic Obstructive Pulmonary Disease (COPD) is a chronic (long-term) lung disease that makes it hard to breathe. It is ...

A BBC health expert has spoken about a simple breathing technique which could help around 1.4 million people in the UK who ...

Precision medicine approaches for chronic obstructive pulmonary disease (COPD) are lagging, creating gaps in care and leaving ...

This is a story about "lung disease," and it is also a story about "your life.""I get more out of breath climbing stairs than ...

Many patients with chronic obstructive pulmonary disease (COPD) have exacerbations despite receiving standard-of-care inhaled ...

Researchers conducted a cohort study to compare lung cancer risk among patients with COPD and T2DM using SGLT2 inhibitors vs sulfonylureas.

Background Pulmonary rehabilitation (PR) is the cornerstone of non-pharmacological treatment for chronic obstructive ...

This document explains the latest research findings regarding combination therapy with patients with severe COPD using L-arginine and liposomal vitamin C. The main study showed that adding these nutri ...

If you have COPD, the sounds made by your lungs can help your doctor evaluate the state of your airways and whether your treatment is working. Types of COPD lung sounds include wheezing, crackling, ...